DOJ Awards $3.36M for Flu Vaccines to Sanofi Pasteur Inc. for Federal Prison System
Contract Overview
Contract Amount: $3,362 ($3.4K)
Contractor: Sanofi Vaccines US Inc.
Awarding Agency: Department of Justice
Start Date: 2026-04-15
End Date: 2026-09-30
Contract Duration: 168 days
Daily Burn Rate: $20/day
Competition Type: FULL AND OPEN COMPETITION
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: FY26 FCI LEAVENWORTH SANOFI PASTEUR INC FLU VACCINES APRIL 2026 IAW T&C: 36E79726D0009 FIRM-FIXED PRICE
Place of Performance
Location: SWIFTWATER, MONROE County, PENNSYLVANIA, 18370
Plain-Language Summary
Department of Justice obligated $3,362.4 to SANOFI VACCINES US INC. for work described as: FY26 FCI LEAVENWORTH SANOFI PASTEUR INC FLU VACCINES APRIL 2026 IAW T&C: 36E79726D0009 FIRM-FIXED PRICE Key points: 1. Sanofi Pasteur Inc. secured a $3.36 million contract for flu vaccines. 2. The contract was awarded under full and open competition. 3. The firm-fixed-price contract covers vaccine delivery from April to September 2026. 4. This spending supports the health and well-being of inmates within the Federal Prison System.
Value Assessment
Rating: good
The $3.36 million award for flu vaccines appears reasonable given the quantity and duration. Benchmarking against similar federal vaccine procurements would provide further validation.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded through full and open competition, suggesting a robust price discovery process. This method typically yields competitive pricing for the government.
Taxpayer Impact: Taxpayers benefit from competitive pricing achieved through an open bidding process, ensuring value for money in public health spending.
Public Impact
Ensures availability of essential flu vaccines for federal inmates. Supports public health initiatives within correctional facilities. Contributes to preventing outbreaks and maintaining a healthy environment for inmates and staff.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Positive Signals
- Full and open competition utilized
- Firm-fixed-price contract type
- Essential public health service
Sector Analysis
This procurement falls within the Pharmaceutical Preparation Manufacturing sector. Federal spending on vaccines is crucial for maintaining public health, particularly in congregate settings like federal prisons.
Small Business Impact
The data indicates this contract was not awarded to small businesses, as 'sb' is false. Future procurements could explore opportunities for small business participation in vaccine distribution or related services.
Oversight & Accountability
The Department of Justice's Federal Prison System is responsible for this procurement. Standard oversight mechanisms for federal contracts, including performance monitoring and payment verification, should be in place.
Related Government Programs
- Pharmaceutical Preparation Manufacturing
- Department of Justice Contracting
- Federal Prison System / Bureau of Prisons Programs
Risk Flags
- Potential supply chain disruption risk
- Dependence on a single supplier for critical health commodity
- Price volatility in future contract renewals
- Accuracy of quantity estimates for vaccine needs
Tags
pharmaceutical-preparation-manufacturing, department-of-justice, pa, delivery-order, under-100k
Frequently Asked Questions
What is this federal contract paying for?
Department of Justice awarded $3,362.4 to SANOFI VACCINES US INC.. FY26 FCI LEAVENWORTH SANOFI PASTEUR INC FLU VACCINES APRIL 2026 IAW T&C: 36E79726D0009 FIRM-FIXED PRICE
Who is the contractor on this award?
The obligated recipient is SANOFI VACCINES US INC..
Which agency awarded this contract?
Awarding agency: Department of Justice (Federal Prison System / Bureau of Prisons).
What is the total obligated amount?
The obligated amount is $3,362.4.
What is the period of performance?
Start: 2026-04-15. End: 2026-09-30.
What is the projected per-unit cost of the flu vaccine under this contract, and how does it compare to market rates?
The total award is $3,362,400 for an unspecified number of vaccine doses over approximately 5 months. Without the quantity of vaccines, a precise per-unit cost cannot be calculated. However, if we assume a typical dose cost of $30-$50, the quantity would range from 67,000 to 112,000 doses. This estimated per-unit cost should be benchmarked against recent federal and commercial flu vaccine contracts to assess value.
What are the potential risks associated with relying on a single supplier, even with full and open competition, for a critical health commodity like flu vaccines?
While competition was utilized, reliance on a single supplier for a critical commodity like flu vaccines carries inherent risks. These include potential supply chain disruptions (manufacturing issues, raw material shortages, shipping delays), price increases in future years if competition diminishes, and limited flexibility if demand surges unexpectedly. Robust contract management and contingency planning are essential to mitigate these risks.
How effective is this procurement strategy in ensuring timely and adequate vaccine supply for the federal prison population, considering the contract's duration?
The firm-fixed-price contract with a defined delivery period (April-September 2026) aims to ensure a timely and adequate supply for the specified timeframe. The effectiveness hinges on Sanofi Pasteur's ability to meet delivery schedules and the accuracy of the initial quantity estimates. The duration covers the typical pre-flu season vaccination period, suggesting a strategic approach to preparedness.
Industry Classification
NAICS: Manufacturing › Pharmaceutical and Medicine Manufacturing › Pharmaceutical Preparation Manufacturing
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Parent Company: Sanofi
Address: 1 DISCOVERY DR, SWIFTWATER, PA, 18370
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Foreign Owned, Foreign-Owned and U.S.-Incorporated Business, Manufacturer of Goods, Not Designated a Small Business, Special Designations
Financial Breakdown
Contract Ceiling: $3,362
Exercised Options: $3,362
Current Obligation: $3,362
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Cost or Pricing Data: NO
Parent Contract
Parent Award PIID: 36E79726D0009
IDV Type: IDC
Timeline
Start Date: 2026-04-15
Current End Date: 2026-09-30
Potential End Date: 2026-09-30 00:00:00
Last Modified: 2026-04-07
More Contracts from Sanofi Vaccines US Inc.
- 00hcvgbc-2009-68767 - Sanofi VFC Pediatric Vaccine Contract — $737.3M (Department of Health and Human Services)
- Vaccince for Children 2010 — $709.2M (Department of Health and Human Services)
- Vaccine for Children 2011 — $640.0M (Department of Health and Human Services)
- Vacccine for Children 2008 Contract — $590.5M (Department of Health and Human Services)
- VFC 2012 — $589.8M (Department of Health and Human Services)
Other Department of Justice Contracts
- Contractor Owned and Operated Existing Correctional Facility for Approximately 3,500 LOW Security Male Inmates — $794.5M (Cornell Companies, Inc.)
- Detention Services - SAN Diego — $776.9M (THE GEO Group, Inc.)
- CO: Telly Renfroe Award of NEW Task Order Base Year Initial Funding — $616.4M (AT&T Enterprises, LLC)
- TAS 151060 - Services for the Management and Operation of a Contractor-Owned, Contractor-Operated, Correctional Facility for 2,567 Beds in Adams County, Mississippi — $574.3M (Corecivic, Inc.)
- Provide Services for the Management and Operation of a Correctional Facility in Accordance With Rfp-Pcc-0014 — $568.9M (Cornell Companies, Inc.)